These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16861242

  • 1. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K, Daniel C, Schöcklmann H, Endlich KH, Kerjaschki D, Johnson RJ, Hugo C.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [Abstract] [Full Text] [Related]

  • 2. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A, Masuda Y, Mori T, Kitamura H, Ishizaki M, Sugisaki Y, Fukuda Y.
    J Am Soc Nephrol; 2004 Oct 15; 15(10):2655-65. PubMed ID: 15466270
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N.
    Am J Pathol; 2001 Aug 15; 159(2):599-608. PubMed ID: 11485918
    [Abstract] [Full Text] [Related]

  • 5. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy.
    Hohenstein B, Braun A, Amann KU, Johnson RJ, Hugo CP.
    Nephrol Dial Transplant; 2008 Apr 15; 23(4):1144-56. PubMed ID: 18045820
    [Abstract] [Full Text] [Related]

  • 6. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M.
    Bone; 2004 Nov 15; 35(5):1144-56. PubMed ID: 15542040
    [Abstract] [Full Text] [Related]

  • 7. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

  • 8. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
    Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, Saruta T, Hishikawa K, Fujita T.
    J Am Soc Nephrol; 2005 Apr 01; 16(4):997-1004. PubMed ID: 15744001
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.
    Daniel C, Renders L, Amann K, Schulze-Lohoff E, Hauser IA, Hugo C.
    Am J Transplant; 2005 Dec 01; 5(12):2849-61. PubMed ID: 16302997
    [Abstract] [Full Text] [Related]

  • 10. Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.
    Zatelli MC, Minoia M, Martini C, Tagliati F, Ambrosio MR, Schiavon M, Buratto M, Calabrese F, Gentilin E, Cavallesco G, Berdondini L, Rea F, degli Uberti EC.
    Endocr Relat Cancer; 2010 Sep 01; 17(3):719-29. PubMed ID: 20554786
    [Abstract] [Full Text] [Related]

  • 11. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen G, Yu D, Floege J.
    J Am Soc Nephrol; 2006 Aug 01; 17(8):2202-12. PubMed ID: 16790513
    [Abstract] [Full Text] [Related]

  • 12. The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat.
    Wittmann S, Daniel C, Braun A, Vogelbacher R, Shimizu F, Kawachi H, Hugo C.
    Nephron Exp Nephrol; 2008 Aug 01; 108(2):e45-56. PubMed ID: 18270495
    [Abstract] [Full Text] [Related]

  • 13. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.
    Diekmann F, Rovira J, Carreras J, Arellano EM, Bañón-Maneus E, Ramírez-Bajo MJ, Gutiérrez-Dalmau A, Brunet M, Campistol JM.
    J Am Soc Nephrol; 2007 Oct 01; 18(10):2653-60. PubMed ID: 17804674
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
    Ko HT, Yin JL, Wyburn K, Wu H, Eris JM, Hambly BD, Chadban SJ.
    Nephrol Dial Transplant; 2013 Feb 01; 28(2):327-36. PubMed ID: 23229928
    [Abstract] [Full Text] [Related]

  • 15. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis.
    Rookmaaker MB, Smits AM, Tolboom H, Van 't Wout K, Martens AC, Goldschmeding R, Joles JA, Van Zonneveld AJ, Gröne HJ, Rabelink TJ, Verhaar MC.
    Am J Pathol; 2003 Aug 01; 163(2):553-62. PubMed ID: 12875975
    [Abstract] [Full Text] [Related]

  • 16. VEGF(165) mediates glomerular endothelial repair.
    Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J.
    J Clin Invest; 1999 Oct 01; 104(7):913-23. PubMed ID: 10510332
    [Abstract] [Full Text] [Related]

  • 17. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 01; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
    Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ.
    Kidney Int; 2000 Dec 01; 58(6):2390-9. PubMed ID: 11115072
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T, Waiser J, Lichter S, Schumann B, Neumayer HH, Kamar N, Budde K.
    Cytokine; 2008 Jun 01; 42(3):306-11. PubMed ID: 18440821
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
    Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE.
    J Am Soc Nephrol; 2006 Mar 01; 17(3):724-35. PubMed ID: 16436493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.